Logo image of CYBR

CYBERARK SOFTWARE LTD/ISRAEL (CYBR) Stock Fundamental Analysis

NASDAQ:CYBR - Nasdaq - IL0011334468 - Common Stock - Currency: USD

382.78  +3.83 (+1.01%)

After market: 382.78 0 (0%)

Fundamental Rating

5

Overall CYBR gets a fundamental rating of 5 out of 10. We evaluated CYBR against 283 industry peers in the Software industry. While CYBR has a great health rating, there are worries on its profitability. CYBR is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CYBR had positive earnings in the past year.
In the past year CYBR had a positive cash flow from operations.
CYBR had negative earnings in each of the past 5 years.
In the past 5 years CYBR always reported a positive cash flow from operatings.
CYBR Yearly Net Income VS EBIT VS OCF VS FCFCYBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

CYBR's Return On Assets of -2.62% is in line compared to the rest of the industry. CYBR outperforms 57.24% of its industry peers.
Looking at the Return On Equity, with a value of -3.60%, CYBR is in the better half of the industry, outperforming 61.84% of the companies in the same industry.
Industry RankSector Rank
ROA -2.62%
ROE -3.6%
ROIC N/A
ROA(3y)-4.42%
ROA(5y)-3.71%
ROE(3y)-10.52%
ROE(5y)-8.79%
ROIC(3y)N/A
ROIC(5y)N/A
CYBR Yearly ROA, ROE, ROICCYBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 -15

1.3 Margins

CYBR has a better Gross Margin (77.91%) than 75.97% of its industry peers.
CYBR's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for CYBR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.94%
GM growth 5Y-1.54%
CYBR Yearly Profit, Operating, Gross MarginsCYBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

7

2. Health

2.1 Basic Checks

CYBR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CYBR has more shares outstanding
CYBR has more shares outstanding than it did 5 years ago.
There is no outstanding debt for CYBR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CYBR Yearly Shares OutstandingCYBR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CYBR Yearly Total Debt VS Total AssetsCYBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

CYBR has an Altman-Z score of 12.96. This indicates that CYBR is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CYBR (12.96) is better than 89.05% of its industry peers.
There is no outstanding debt for CYBR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 12.96
ROIC/WACCN/A
WACC9.5%
CYBR Yearly LT Debt VS Equity VS FCFCYBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

CYBR has a Current Ratio of 1.29. This is a normal value and indicates that CYBR is financially healthy and should not expect problems in meeting its short term obligations.
CYBR has a Current ratio (1.29) which is in line with its industry peers.
CYBR has a Quick Ratio of 1.29. This is a normal value and indicates that CYBR is financially healthy and should not expect problems in meeting its short term obligations.
CYBR has a Quick ratio (1.29) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.29
CYBR Yearly Current Assets VS Current LiabilitesCYBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

9

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 62.19% over the past year.
CYBR shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.81% yearly.
The Revenue has grown by 35.13% in the past year. This is a very strong growth!
CYBR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.19% yearly.
EPS 1Y (TTM)62.19%
EPS 3Y111.56%
EPS 5Y1.81%
EPS Q2Q%30.67%
Revenue 1Y (TTM)35.13%
Revenue growth 3Y25.78%
Revenue growth 5Y18.19%
Sales Q2Q%43.35%

3.2 Future

Based on estimates for the next years, CYBR will show a very strong growth in Earnings Per Share. The EPS will grow by 27.96% on average per year.
The Revenue is expected to grow by 24.17% on average over the next years. This is a very strong growth
EPS Next Y28.5%
EPS Next 2Y27.96%
EPS Next 3Y29.78%
EPS Next 5Y27.96%
Revenue Next Year33.63%
Revenue Next 2Y26.38%
Revenue Next 3Y24.47%
Revenue Next 5Y24.17%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CYBR Yearly Revenue VS EstimatesCYBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B 4B
CYBR Yearly EPS VS EstimatesCYBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 5 10 15

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 117.42 indicates a quite expensive valuation of CYBR.
CYBR's Price/Earnings ratio is in line with the industry average.
CYBR's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.25.
CYBR is valuated quite expensively with a Price/Forward Earnings ratio of 77.15.
The rest of the industry has a similar Price/Forward Earnings ratio as CYBR.
When comparing the Price/Forward Earnings ratio of CYBR to the average of the S&P500 Index (22.15), we can say CYBR is valued expensively.
Industry RankSector Rank
PE 117.42
Fwd PE 77.15
CYBR Price Earnings VS Forward Price EarningsCYBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

CYBR's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 77.13
EV/EBITDA N/A
CYBR Per share dataCYBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as CYBR's earnings are expected to grow with 29.78% in the coming years.
PEG (NY)4.12
PEG (5Y)64.85
EPS Next 2Y27.96%
EPS Next 3Y29.78%

0

5. Dividend

5.1 Amount

CYBR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CYBERARK SOFTWARE LTD/ISRAEL

NASDAQ:CYBR (5/30/2025, 8:00:00 PM)

After market: 382.78 0 (0%)

382.78

+3.83 (+1.01%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-13 2025-05-13/bmo
Earnings (Next)08-06 2025-08-06/bmo
Inst Owners91.4%
Inst Owner Change0.43%
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap19.25B
Analysts85.91
Price Target448.34 (17.13%)
Short Float %2.23%
Short Ratio1.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.67%
Min EPS beat(2)9.13%
Max EPS beat(2)22.2%
EPS beat(4)4
Avg EPS beat(4)41.57%
Min EPS beat(4)9.13%
Max EPS beat(4)101.67%
EPS beat(8)8
Avg EPS beat(8)75.35%
EPS beat(12)12
Avg EPS beat(12)62.19%
EPS beat(16)15
Avg EPS beat(16)50.27%
Revenue beat(2)2
Avg Revenue beat(2)2.15%
Min Revenue beat(2)2.01%
Max Revenue beat(2)2.3%
Revenue beat(4)4
Avg Revenue beat(4)1.36%
Min Revenue beat(4)0.54%
Max Revenue beat(4)2.3%
Revenue beat(8)7
Avg Revenue beat(8)1.56%
Revenue beat(12)8
Avg Revenue beat(12)0.45%
Revenue beat(16)9
Avg Revenue beat(16)0.16%
PT rev (1m)0%
PT rev (3m)-1.51%
EPS NQ rev (1m)3.57%
EPS NQ rev (3m)2.34%
EPS NY rev (1m)4.51%
EPS NY rev (3m)4.22%
Revenue NQ rev (1m)1.58%
Revenue NQ rev (3m)2.14%
Revenue NY rev (1m)0.37%
Revenue NY rev (3m)0.22%
Valuation
Industry RankSector Rank
PE 117.42
Fwd PE 77.15
P/S 17.55
P/FCF 77.13
P/OCF 73.54
P/B 7.93
P/tB 45.07
EV/EBITDA N/A
EPS(TTM)3.26
EY0.85%
EPS(NY)4.96
Fwd EY1.3%
FCF(TTM)4.96
FCFY1.3%
OCF(TTM)5.21
OCFY1.36%
SpS21.81
BVpS48.27
TBVpS8.49
PEG (NY)4.12
PEG (5Y)64.85
Profitability
Industry RankSector Rank
ROA -2.62%
ROE -3.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.91%
FCFM 22.76%
ROA(3y)-4.42%
ROA(5y)-3.71%
ROE(3y)-10.52%
ROE(5y)-8.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.94%
GM growth 5Y-1.54%
F-Score4
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 17.53%
Cap/Sales 1.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 1.29
Altman-Z 12.96
F-Score4
WACC9.5%
ROIC/WACCN/A
Cap/Depr(3y)43.07%
Cap/Depr(5y)47.67%
Cap/Sales(3y)1.29%
Cap/Sales(5y)1.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)62.19%
EPS 3Y111.56%
EPS 5Y1.81%
EPS Q2Q%30.67%
EPS Next Y28.5%
EPS Next 2Y27.96%
EPS Next 3Y29.78%
EPS Next 5Y27.96%
Revenue 1Y (TTM)35.13%
Revenue growth 3Y25.78%
Revenue growth 5Y18.19%
Sales Q2Q%43.35%
Revenue Next Year33.63%
Revenue Next 2Y26.38%
Revenue Next 3Y24.47%
Revenue Next 5Y24.17%
EBIT growth 1Y-13.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year117.82%
EBIT Next 3Y45.05%
EBIT Next 5YN/A
FCF growth 1Y1271.32%
FCF growth 3Y49.72%
FCF growth 5Y10.39%
OCF growth 1Y758.3%
OCF growth 3Y45.88%
OCF growth 5Y10.35%